NCT07049341: An ongoing trial by NeuroEM Therapeutics, Inc.
This trial is ongoing. It must report results 3 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07049341 |
|---|---|
| Title | Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 31, 2025 |
| Completion date | June 30, 2028 |
| Required reporting date | June 30, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |